VIDRAFT's PharmaOS Lands Government-Pharma Program to Drive AI-Discovered Small-Molecule Cancer Drug Candidates to Preclinical
This story is from 2026-09-08. It is preserved in the archive; the latest stories are on the live feed.
VIDRAFT's PharmaOS Lands Government-Pharma Program to Drive AI-Discovered Small-Molecule Cancer Drug Candidates to Preclinical TL;DR: VIDRAFT, a Korean AI-foundry deep-tech company, has been selected for the South Korean government's "Challenge Bio" open-innovation program to discover and validate…
Read the full story at DEV Community — Machine Learning ↗
Timeline · 1 report
- 2026-09-08 03:01 · DEV Community — Machine Learning
VIDRAFT's PharmaOS Lands Government-Pharma Program to Drive AI-Discovered Small-Molecule Cancer Drug Candidates to Preclinical